Condition
Local Recurrence of Malignant Tumor of Prostate
Total Trials
3
Recruiting
2
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Recruiting2
Active Not Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06982469Recruiting
High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy
NCT06201078Phase 2RecruitingPrimary
Stereotactic Re-irradiation of Local Recurrences of Prostate Cancer After Radiotherapy
NCT03438552Not ApplicableActive Not RecruitingPrimary
Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor Recurrence
Showing all 3 trials